GlassScriptPhysician profile
James A Thompson
NPI 1295963528
$1,953.04
in general payments reported to CMS, 2019-2025
19 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $341 · 2020: $147 · 2021: $272 · 2022: $799 · 2023: $150 · 2024: $126 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $393.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,192.35 | 2022-2025 | Amplatzer Piccolo, Amplatzer |
| Biohaven Pharmaceuticals, INC. | $172.08 | 2021 | |
| Merck Sharp & Dohme LLC | $143.10 | 2019-2021 | |
| Lilly USA, LLC | $66.05 | 2020-2021 | |
| Amag Pharmaceuticals, INC. | $53.88 | 2019 | |
| Novo Nordisk INC | $52.44 | 2019 | |
| Abbvie INC. | $45.68 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $40.47 | 2019-2021 | |
| Sanofi Pasteur INC. | $30.46 | 2019-2020 | |
| Amgen INC. | $26.40 | 2019-2020 | |
| Agile Therapeutics, INC. | $18.21 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $17.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.40 | 2020 | |
| Daiichi Sankyo INC. | $15.65 | 2019 | |
| Insulet Corporation | $15.42 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $14.76 | 2019 | |
| Coopersurgical, INC. | $13.60 | 2019 | |
| Shire North American Group INC | $12.25 | 2019 | |
| Kvk-Tech, INC. | $6.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.